INSIGHTS ON DRUG DEVELOPMENT

• What Role Does QbD Play In Pharmaceutical Feasibility Studies?

  Because drug development can present many challenges, including issues with quality or inefficient processes, it is always necessary to jointly develop a feasibility plan where the key processing parameters and steps are tested.

• Liposomal And Nanoparticle Technology At Pfizer Melbourne

  In recent years, liposome technologies have become an important part of the drug delivery armory, with several marketed products now available for use and many more formulations being evaluated in clinical trials.

• Spray-Dried Dispersions Enable Local Delivery For Lung Cancer

  Spray drying is a useful particle engineering technique that can deliver the particles within the necessary specifications and can therefore be used to manufacture dry powder inhaler treatments. Learn more about spray drying, and discover two case studies detailing its success.

• Probing The Source Of An Unstable Impurity And Controlling Its Formation At Release

  A critical step in an extended-release drug product analysis is the extraction during impurity and assay sample preparation. When both the drug substance and the impurity are unstable, this is especially challenging.

• Drug Repurposing Trends And Strategic Approaches For Shortening Timelines

  4/15/2021

  As the complexity of drug development increases, so does the industry’s focus on strategies and solutions that can help bring advanced products to market as quickly as possible.

• The Changing Dynamics Of The Pharma/Biotech Supply Chain – A Packaging And Clinical Supply Perspective

  3/29/2021

  Perhaps more than any other industry, pharma and biotech have undergone radical change over the past year, as a result of the COVID-19 pandemic. From supply chain security and capacity to clinical trial operations and site auditing, almost every aspect has been affected. Experts explore how these trends are shaping the industry and offer an outlook.

• Rentschler Biopharma Corporate Presentation

  3/29/2021

  We empower our clients to help patients with serious or rare diseases. With our dedication and expertise, we convert medical research into outstanding biopharmaceuticals.

• Bayer Evaluates Fibro For Scalable Single-Use mAb Purification

  3/22/2021

  Learn how Bayer evaluated Fibro PrismA chromatography to determine its potential as a true single-use mAb capture technology. They assessed scalability from lab- to process-scale tracking pressure drop, step recovery, purity, and eluate volumes across multiple cycles. Read the outcome here.